Connection

Emilio Attena to Atrial Fibrillation

This is a "connection" page, showing publications Emilio Attena has written about Atrial Fibrillation.
Connection Strength

0.338
  1. Clinical characteristics and prognosis of hospitalized COVID-19 patients with incident sustained tachyarrhythmias: A multicenter observational study. Eur J Clin Invest. 2020 Dec; 50(12):e13387.
    View in: PubMed
    Score: 0.076
  2. Real-life Performance of Edoxaban in Elderly Patients With Atrial Fibrillation: a Multicenter Propensity Score-Matched Cohort Study. Clin Ther. 2019 08; 41(8):1598-1604.
    View in: PubMed
    Score: 0.069
  3. Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study. Biomed Res Int. 2019; 2019:5473240.
    View in: PubMed
    Score: 0.068
  4. Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience. Semin Thromb Hemost. 2018 Jun; 44(4):364-369.
    View in: PubMed
    Score: 0.063
  5. Use of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Malignancy: Clinical Practice Experience in a Single Institution and Literature Review. Semin Thromb Hemost. 2018 Jun; 44(4):370-376.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.